Clinical trial
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200 is registered in ClinicalTrials.gov with Chinese Pulmonary Vascular Disease Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
- Lead sponsor
- Chinese Pulmonary Vascular Disease Research Group
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2020
- Completion date
- December 31, 2025
- Enrollment
- 480 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
epidemiology, mortality, obstructive sleep apnea, outcomes, predictor, prognosis, pulmonary hypertension, sleep apnea